The situation of the members of New EPS recorded a new episode after I found out Medicarte SAS will stop supplying medicines from January 1, 2026a decision added to that previously announced by Colsubsidio.
The information was published by the Patients Colombia organization, which announced the company’s notice to health system users, the magazine reported Week.
According to Pacientes Colombia, Medicarte’s determination affects an EPS currently intervened by the national government, which is about 50% 11 million from subsidiaries across the country. The suspension adds to a series of contractual changes that have impacted drug delivery in recent months.
In the statement cited by the organization, Medicarte explained the context of its decision. “At Medicarte SAS we have always understood our work as a genuine commitment to the life, care and dignity of each of our patients.”indicates the text that the Company makes available to Nueva EPS users.
The company said the payment difficulties were not new. In the same document, Medicarte recalled this “In February 2025 we informed Nueva EPS of the end of the contractual relationship”a process that the company said was delayed several times before final termination of the agreement was finalized.
This was spelled out in the letter The attention for Nueva EPS members only lasts until December 31, 2025. From this date, the consulting services, applications, medication dispensing and other services offered by Medicarte must be taken over by the new provider named by EPS.
The document also indicated this “From January 1, 2026, consultations, medication applications and dispensing, and other services provided by Medicarte will be provided by the new provider designated by your EPS.”and encouraged users to contact Nueva EPS directly for further information.
The departure of Medicarte is in addition to that announced Colsubsidya company that confirmed it will stop dispensing medication to Nueva EPS members later this year 2026. This decision came in a context in which EPS is one of the main debtors of both pharmaceutical managers and the country’s hospitals and clinics.
Given this scenario Nueva EPS reported the activation of an emergency plan to ensure continuity of service. The company announced that the supply of medicines will be handled by a new network of pharmaceutical managers consisting of Cafam, Medic, Discolmets, Audifarma, Farmicall and Tododrogas.
These operators will reportedly be responsible for dispensing medication 11 departments where Colsubsidio provided the service. The EPS noted that this reorganization aims to meet user demand in the areas affected by the contract termination.
The financial situation of Nueva EPS was also analyzed by industry experts. Granted in an interview WEEKthe former health minister Augusto Galancurrent director of the Así Vamos en Salud program, referred to the panorama facing the company.
“The risk of the new EPS disappearing is very high. The day may come when it can no longer pay its debts.”said Galán, explaining that the company remains operational thanks to a constant flow of monthly resources.
The former minister explained that the EPS receives between 1.8 and 2 billion pesos per monthwhile providers’ bills exceed this amount. “I don’t dare give numbers because there are no official reports”he noted, citing the lack of consolidated public information.
Galan also emphasized this The eventual liquidation of Nueva EPS would have a significant impact on the healthcare systemtaking into account the affiliate volume. The company currently serves approximately 11 million of the people in the country.
In this context he warned against it “The liquidation of an EPS is a decision of its administrators and of Supersalud”and explained that the operation could continue, albeit with limitations in care, in a unit that is almost grouped 12 million of the affiliated companies.
The former minister also noted the impact on healthcare providers. According to him, there are still outstanding contracts and invoices with Nueva EPS, which raises questions Who would make these payments and in what form?a situation that could affect several institutions in the industry.
About The Author
